Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

World Stem Cell Report to be Published in Regenerative Medicine

Published: Thursday, April 14, 2011
Last Updated: Thursday, April 14, 2011
Bookmark and Share
The Genetics Policy Institute (GPI) and Future Medicine have announced that its 2011/12 World Stem Cell Report will be published as a special supplement to the award-winning, peer-reviewed journal Regenerative Medicine.

It was also announced that Regenerative Medicine becomes the platinum media sponsor of the GPI’s 2011 World Stem Cell Summit that will take place in Pasadena, California, October 3-5.

Bernard Siegel, Executive Director of GPI said, “We are proud to partner with the truly superb editorial team at Regenerative Medicine to elevate the World Stem Cell Report to PubMed status. This collaboration will allow the Report to reach an even broader global audience. We will continue to provide an array of specialized articles offering unique insights of leading policy-makers, regulators and experts in law, ethics, advocacy, industry and philanthropy from countries, regions and states. The Report provides a critical unmet need by providing a global framework to understand how the intersection of ethics, law, economics and society impact the advancement of regenerative medicine and the quest for cures.”

Elisa Manzotti, Editorial Director at Future Medicine said “We are delighted to be working with Bernie Siegel and GPI on this exciting collaboration. Our editorial team will take great care to ensure that the World Stem Cell Report articles deliver concise, timely and actionable intelligence to our readers. In becoming a platinum media sponsor of the World Stem Cell Summit, we recognize the Summit’s important role in bringing together leaders from around the globe to chart the future of regenerative medicine.”

The Report will be made available to all attendees at the World Stem Cell Summit. The Summit is the world’s largest interdisciplinary stem cell meeting and is organized this year by GPI, City of Hope, Cedars-Sinai Regenerative Medicine Institute, California Institute of Technology and the California Institute for Regenerative Medicine (CIRM).

The Summit program will feature 170 prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers and experts in law and ethics, who will discuss the latest scientific discoveries, business models, legal and regulatory solutions and best practices.

The Summit is expected to attract more than 2,000 attendees from 25 nations, 60 exhibitors and more than 150 endorsing organizations and media partners.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stem Cells Derived from Amniotic Fluid no Substitute for Embryonic Cells
The GPI welcomes the discovery of versatile stem cells in amniotic fluid as a positive development while cautioning that it does not eliminate the need for embryonic stem cell research.
Wednesday, January 10, 2007
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos